Please login or sign up to post and edit reviews.
TWiV 967: Clinical update with Dr. Daniel Griffin
Media Type |
audio
Categories Via RSS |
Medicine
Science & Medicine
Publication Date |
Dec 24, 2022
Episode Duration |
00:50:45

In his weekly clinical update Dr. Griffin discusses how immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with Influenza, WHO estimates of excess mortality associated with the COVID-19 pandemic, reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection post-vaccination for mild COVID-19 patients, impact of SARS-CoV-2 variants on inpatient clinical outcome, clinical features and burden of post-acute sequelae of SARS-CoV-2 infection in children and adolescents, similar SARS-CoV-2 Ct value distributions in anterior nares versus nasopharyngeal samples from symptomatic children during Delta and Omicron surges, early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19, effect of Nirmatrelvir/Ritonavir vs Placebo on COVID-19─related hospitalizations and other medical visits, COVID-19 Convalescent Plasma outpatient therapy to prevent outpatient hospitalization, bacterial co-infection and empirical antibiotic therapy in patients with COVID-19, association of time to surgery after COVID-19 infection with risk of postoperative cardiovascular morbidity, demonstration of stable clusters of symptoms in long COVID, and how longitudinal analysis of t cells in COVID-19 survivors with post-acute sequelae of COVID-19 reveals associations between individual symptoms and inflammatory indexes.

Subscribe (free): Apple PodcastsGoogle PodcastsRSSemail

Become a patron of TWiV!

Links for this episode

Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In his weekly clinical update Dr. Griffin discusses how immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Immunological dysfunction persists for 8 months following SARS-CoV-2 infection (Nature) Prevalence of SARS-CoV-2 and Influenza coinfection and clinical characteristics (CDC) WHO estimates of excess mortality associated with the COVID-19 pandemic (Nature) Reconsideration of anti-nucleocapsid IgG antibody as a marker of SARS-CoV-2 infection (OFID) Impact of SARS-CoV-2 variants on inpatient clinical outcome (CID) Clinical features and burden of post-acute sequelae of SARS-CoV-2 infection (OFID) Similar SARS-CoV-2 Ct value distributions in samples from symptomatic children (JPIDS) Early estimates of bivalent mRNA vaccine effectiveness in preventing COVID-19 (CDC) Effect of Nirmatrelvir/Ritonavir vs placebo on COVID-19─Related hospitalizations (OFID) COVID-19 Convalescent Plasma outpatient therapy to prevent outpatient hospitalization (MedRxiv) Bacterial co-infection and empirical antibiotic therapy in patients with COVID-19 (OFID) Association of time to surgery after COVID-19 infection (JAMA) Demonstration of stable clusters of symptoms in long COVID (OFID) Paxlovid patient eligbiliity screening checklist (FDA) Longitudinal analysis of T cells in COVID-19 survivors with post-acute sequelae (OFID) Contribute to our MicrobeTV fundraiser at PWB Dr. Griffin’s treatment guide (pdf) Letters read on TWiV 967 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv

In his weekly clinical update Dr. Griffin discusses how immunological dysfunction persists for 8 months following initial mild-to-moderate SARS-CoV-2 infection, prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review